Auxly Cannabis - CEO, Hugo Alves
CEO, Hugo Alves
Source: Canadian Lawyer
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Auxly Cannabis (TSXV:XLY) subsidiary, Robinsons Cannabis, has gained Health Canada’s authorisation to sell dried cannabis in Canada
  • The sales license expands the company’s current product portfolio, to include artisan hand-crafted cannabis flower
  • Robinsons has been growing small-batch cannabis at its Nova Scotia facility since obtaining its initial cultivation license
  • The company expects its dried cannabis products to become available in certain Canadian provinces this summer
  • Auxly Cannabis (XLY) is up 2.35 per cent and is currently trading at C$0.44 per share

Auxly Cannabis (TSXV:XLY) subsidiary, Robinsons Cannabis, has gained Health Canada’s authorisation to sell dried cannabis in Canada.

The sales license from the authority applies to Canadian provinces and territories under the country’s Cannabis Regulations.

With the addition of artisan, hand-crafted dried cannabis flower, the license also expands Auxly’s current product portfolio. The company and its subsidiary will produce the dried cannabis for Canada’s premium craft market. 

Since obtaining an initial license for cultivation, Robinsons has been growing small-batch premium cannabis at its Nova Scotia facility. The state-of-the-art facility is 27,700 square feet and is located in Kentville. 

The subsidiary’s cannabis cultivation processes are all overseen by the company’s founder and Master Grower, Andrew Robinson. Under his supervision, Robinsons boasts a uniquely premium product for connoisseurs of cannabis. 

Auxly’s CEO, Hugo Alves, commented on receiving Health Canada’s authorisation.

“We couldn’t be more excited to obtain this sales licence for Robinsons – a key milestone for Auxly as we continue to execute our vision of being a leader in branded cannabis products.

“Congratulations to the talented team at Robinsons who are growing what I believe is the best cannabis in Canada. Also, special thanks to Health Canada for their ability to facilitate this licence in the midst of unique challenges presented by the COVID-19 pandemic,” he said.

With the sales license from Health Canada in hand, Auxly expects to make its dried cannabis products available soon. The company anticipates that its cannabis flower will be available in select Canadian provinces this summer.

Auxly Cannabis (XLY) is up 2.35 per cent and is trading at C$0.44 per share at 11:05am EDT.

More From The Market Herald

" The Market Herald’s Weekly Cannabis Report – June 2, 2023

Avicanna Inc. (TSX:AVCN) has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" Shoppers Drug Mart exits medical cannabis business

Avicanna has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" The Market Herald’s Weekly Cannabis Report – May 26, 2023

Tilray Brands Inc. (TSX:TLRY) has received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds.